Roivant Sciences (ROIV) Net Cash Flow (2020 - 2026)

Roivant Sciences (ROIV) has 6 years of Net Cash Flow data on file, last reported at -$1.2 billion in Q4 2025.

• Quarterly Net Cash Flow rose 72.76% year-over-year to -$1.2 billion in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$2.7 billion (up 70.03% YoY) and the FY2026 annual result came in at -$1.3 billion, up 66.06% from the prior year.
• Net Cash Flow fell to -$1.2 billion in Q4 2025, from -$2.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $5.0 billion in Q4 2023 to a low of -$4.6 billion in Q4 2024.
• A 5-year average of -$507.4 million and a median of -$242.4 million in 2023 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2023 — Net Cash Flow soared 1036.57% — and 2024, when it plunged 14574.37%.
• Tracing ROIV's Net Cash Flow over 5 years: stood at $84.5 million in 2021, then tumbled by 731.07% to -$533.0 million in 2022, then soared by 1036.57% to $5.0 billion in 2023, then slumped by 191.15% to -$4.6 billion in 2024, then soared by 72.76% to -$1.2 billion in 2025.
• The last three Net Cash Flow figures came in at -$1.2 billion (Q4 2025), -$2.7 million (Q3 2025), and -$1.5 billion (Q2 2025), per Business Quant data.